Effects of vitex agnus castus on mice fetus development

Acta Medica Iranica

Volumn 45, Issue 4, 2007, Pages 263-270

  Azarnia, M ^a   Ejtemaee Mehr, S ^b   Shakoor, A ^c   Ansari, A ^a,b  

^a KHARAZMI UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Legal Medicine Organization   (Iran)

Author keywords

Mice fetus development; Vitex agnus castus

Indexed keywords

VITEX AGNUS CASTUS EXTRACT;

ARTICLE; CONTROLLED STUDY; CROWN RUMP LENGTH; EMBRYO; EMBRYO GROWTH; EYE; FEMALE; FETUS; FETUS DEVELOPMENT; MEDICAL RESEARCH; MICROSCOPY; MOUSE; NONHUMAN; PLACENTA; PREGNANCY; TREATMENT CONTRAINDICATION; VITEX AGNUS CASTUS; WEIGHT;

EID: 36249021509     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Donald J, Brow ND, 1994, Vitex agnus castus clinical monograph, Herbal Research Review 1994.
2. Ohyama K, Akaike T, Hirobe C, Yamakawa T. Cytotoxicity and apoptotic inducibility of Vitex agnus-castus fruit extract in cultured human normal and cancer cells and effect on growth. Biol Pharm Bull. 2003 Jan; 26(1):10-8.
3. Berger D, Schaffner W, Schrader E, Meier B, Brattstrom A. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet. 2000 Nov; 264(3):150-153.
4. Jarry H, Leonhardt S, Wuttke W, Behr B, Gorkow C. Agnus castus als dopaminerges wirkprinzip in mastodynon phytotherapie 1991;. 12 77-82.
5. Kubista E, Muller G, Spona J. Behandlung der mastopathie mit zyklischer mastodynie, Klinische ergebnisse und hormonprofil, Gynakologische Rundschav 1986; 26 65-75.
6. Hobbs C. Vitex: the women's herb, Botanica press, Santa Cruz, CA 1996.
7. Lauritzen C, Reuter HD, Repges R, Bohnert KJ, Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled double-blind study versus pyridoxine, phytomedicine 1997; 4 185-189.
8. Merz PG, Gorkow C, Schrodter A, Rietbrock S, Sieder C, Loew D , Dericks-Tan JS, Taubert HD. The effects of a special agnus castus extract (HB 1095E1) on prolactin secretion in healthy male-subjects. Exp Clin Endrinol Diabetes 1996;. 104 447-453.
9. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study. Brit Med J 2001; 322 134-137.
10. Sliutz G, Speiser P, Schultz AM, Spona J, Zeillinger R. Agnus castus extract inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 1993; 25 253-255.
11. Liu J, Burdette JE, Sun y, Deng S, Schlecht SM, Zheng W, Nikolic D, Mahady G, Van Breemen RB, Fong HS, Pezzuto JM, Bolton, JL, and Farnsworth NR. Isolation of linoleic acid as an estrogenic compound from the fruits of vitex agnus castus L.(Chaste-berry), phytomedicine 2004; 11 18-23.
12. Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, Schmitz H. [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittelforschung. 1993 Jul; 43(7):752-756. German.
13. Bhargava SK. Antiandrogenic effects of a flavonoid-rich fraction of Vitex negundo seeds: a histological and biochemical study in dogs. J Ethnopharmacol. 1989 Dec; 27(3):327-339.
14. Goma CS, 1978, Flavonoids and irridoids from vitex agnus castus, Planta Medica, 33 277.
15. Hirobe C, Qiao ZS, Takeya K, Itokawa H. Cytotoxic flavonoids from Vitex agnus-castus. Phytochemistry. 1997 Oct; 46(3):521-524.
16. Hoberg E, Orjala J, Meier B, Sticher O. Diterpenoids from the fruits of vitex agnus castus. Phytochemistry 1999; 52 1555-1558.
17. Anonymous, Chaste tree. In. Dombeck C, ed. Lawerence Review of Natural products. St. Louis: Facts and comparisons 1998.
18. Snow JM. Vitex agnus castus L., The Protocol Journal of Botanical Medicine. Spring 1996; 20-23.
19. Fleming T. PDR for herbal medicines. Montvale, NJ. Medical economics company, Inc 1998.
20. Du Mee C. Vitex agnus castus. Aust J Med Herbalism. 5 63-65.
21. Males Z, Blazevic N, Antolic A. The Essential Oil Composition of Vitex agnus-castus f. rosea Leaves and Flowers. Planta Med. 1998 Apr; 64(3):286-287.
22. Welte- Peters C, Abrecht M. Menstrual cycle disorders and PMS, study on the use of vitex agnus castus, TW Gynakologie 1994; 7(1) 49-52.
23. Propping D. Vitex agnus castus treatment of gynecological syndromes, Therapeuitikon 1991; 5 581-585.
24. Newall CA, Anderson LA, Phillipson JD, Herbal medicines, A guide for health-care professionals, London: Pharmaceutical press, 1996: ix, 296.
25. Telang RS, Chatterjee S, Varshneya C. Studies on analgesic and anti-inflammatory activities of V.negundo L. Indian J pharmacol 1999; 31 363-366.
26. Ravishankar B, Bhaskaran NR, Sasikala CK. Pharmacological evaluation of V. negundo (Nirgundi) leaves. Bull Med Ethano Biol Res 1985; 6 72-92.
27. Tendon V, Gupta RK. Histomorphological changes induced by Vitex negundo in albino rats, Indian J pharmacol 2004; 36(3) 175-180.
28. Hernandez MM, Haraso C, Villarre AL ML, Vargas-Arispuro I, Aranda E. Biological activities of crude plant extracts form Vitex trifolia L.(verbenaceae), Journal of Ethno pharmacology 1999; 67(1) 37-44.
29. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HH. Potential value of plants as sources of new antifertility agents I. J Pharm Sci. 1975 Apr; 64(4):535-398.
30. Weiss RF. Herbal Medicine, Beaconsfield Arkana, Beaconsfield, UK 198833. Sanderson J, Mclauchlan WR, Williamson G. Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens, Free Radical Biology & Medicine 1999; 26 639-645.
31. Boomsma D, Paoletti J. A Review of current research on the effects of progesterone, International Journal of Pharmaceutical compounding 2002;.6 (4).
32. Schroder-Van Der Elst JP, Van Per Heide D, Rokas H, Morreale De Escobar G, and kohrle J. Synthetic flavornoids cross the placenta in the rat and are found in fetal brain, Am J Physiol Endocrinol Metab 1998; 274 E253-E256.